Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.
Publication
, Journal Article
López, G; Oberheim Bush, NA; Berger, MS; Perry, A; Solomon, DA
Published in: Acta Neuropathol Commun
May 15, 2017
Duke Scholars
Published In
Acta Neuropathol Commun
DOI
EISSN
2051-5960
Publication Date
May 15, 2017
Volume
5
Issue
1
Start / End Page
38
Location
England
Related Subject Headings
- Young Adult
- Prognosis
- Mutation
- Humans
- Histones
- Glioma
- Female
- Brain Neoplasms
- Brain
- 3209 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
López, G., Oberheim Bush, N. A., Berger, M. S., Perry, A., & Solomon, D. A. (2017). Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun, 5(1), 38. https://doi.org/10.1186/s40478-017-0440-x
López, Giselle, Nancy Ann Oberheim Bush, Mitchel S. Berger, Arie Perry, and David A. Solomon. “Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.” Acta Neuropathol Commun 5, no. 1 (May 15, 2017): 38. https://doi.org/10.1186/s40478-017-0440-x.
López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA. Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun. 2017 May 15;5(1):38.
López, Giselle, et al. “Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.” Acta Neuropathol Commun, vol. 5, no. 1, May 2017, p. 38. Pubmed, doi:10.1186/s40478-017-0440-x.
López G, Oberheim Bush NA, Berger MS, Perry A, Solomon DA. Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun. 2017 May 15;5(1):38.
Published In
Acta Neuropathol Commun
DOI
EISSN
2051-5960
Publication Date
May 15, 2017
Volume
5
Issue
1
Start / End Page
38
Location
England
Related Subject Headings
- Young Adult
- Prognosis
- Mutation
- Humans
- Histones
- Glioma
- Female
- Brain Neoplasms
- Brain
- 3209 Neurosciences